Muscular dystrophy treatment with Tamoxifen and Raloxifene

Researchers study the use of selective estrogen receptor modulators tamoxifen and raloxifene in patients with muscular dystrophies (MD). Results in an animal study showed significant improvement muscular function. The study findings are published in journal American Journal of Pathology.Animal study results showing improvement in grip strength, running and changes in muscle histology following use of … Continue reading Muscular dystrophy treatment with Tamoxifen and Raloxifene

Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health

In patients with invasive breast cancer treated in a general community health care setting, Tamoxifen, Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community and that risk progressively decreased as the duration of tamoxifen therapy increased, according to a new study published online by JAMA Oncology. ¬†About 5 percent of patients … Continue reading Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health